The key technologies used in the diagnosis of mycoplasma infections are
polymerase chain reaction (PCR), immunoassay, microbial culture techniques, and
DNA staining. Of all the key segments, PCR method dominated the market in 2016
and its demand is projected to rise substantially through 2024. The popularity
is attributed to increasing incidence of hospital-acquired and healthcare-associated
infections world over.
Regionally, North America led the global market with its dominant share
in 2016. The extensive uptake of diagnostics for mycoplasma pneumoniae
infections is attributed to the large number of laboratories present across the
region and the heightened awareness among patient populations.
Request
COVID Analysis on Mycoplasma Diagnostics Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1677
High Morbidity and Mortality of Respiratory Tract
Infections bolster Demand for Mycoplasma Infections Diagnostics
The global market for mycoplasma infections diagnostics is driven
primarily by the growing prevalence of respiratory tract infections that can
lead to incidence of lung cancer, tuberculosis, and obstructive pulmonary
diseases. In addition, the concomitant rise in the associated mortality in
worldwide populations is bolstering the demand for mycoplasma diagnostics. The
rising demand for laboratory investigation for the diagnosis of mycoplasma
pneumoniae pathogens is propelling the growth of the market.
The rapid rise in geriatric population, especially in developing and
developed nations, who are increasingly prone to respiratory tract infections
is a crucial factor catalyzing the growth of the market. The rising awareness
of the multiple etiologies that mycoplasma infections harbors among worldwide
communities has accentuated the need for direct pathogen detection.
Furthermore, the rising healthcare infrastructure spending by public and
private players in developed regions is likely to help in the rapid expansion
of the global market.
Request
Customization on Mycoplasma Diagnostics Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1677
Lack of Reliability of Laboratory Tests and High
Cost hindering Widespread Uptake
Despite the rapidly rising demand for mycoplasma diagnostics, few
factors are hindering the uptake. The high cost of the devices and
consumables used in the testing kits for the infections is one of them. The
lack of reliability of these tests in correcting determining microbiological
etiology for mycoplasma pneumoniae also acts as a bottleneck in the growth of
the market. Furthermore, the market is suffering notable setbacks in advanced
nations of North America and Europe owing to stringent regulator norms for the
approval of diagnostics or laboratory testing methods.
Nevertheless, the market is likely to witness exciting avenues arising
out of substantial advancements in PCR-related methods and molecular biology
technologies in recent years. Advancement in diagnostic techniques in recent
years has consistently upped their effectiveness, which has helped healthcare
providers and caregivers in ascertaining the severity of the diseases before it
turns into an epidemics.
Buy
Mycoplasma Diagnostics Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=1677<ype=S
The study presented here is based on a report by Transparency Market
Research (TMR) titled “Mycoplasma Diagnostics Market (Product - Kits &
Reagents, Instruments, and Software & Services; Technology - PCR,
Immunoassay (ELISA and RIA), DNA Staining, and Microbial Culture Techniques;
End User - Hospitals, Diagnostic Laboratories, and Clinics) - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast 2016–2024.”
Key Takeaways:
·
·
The global mycoplasma diagnostics market is segmented based on:
Product
·
·
·
Technology
·
·
o
o
·
·
·
End User
·
·
·
·
Region
·
o
o
·
o
o
o
o
o
o
·
o
o
o
o
·
o
o
o
·
o
o
o
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders, consultants, and
strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve,
and mature. Our real-time data collection methods along with ability to track
more than one million high growth niche products are aligned with your aims.
The detailed and proprietary statistical models used by our analysts offer
insights for making right decision in the shortest span of time. For
organizations that require specific but comprehensive information we offer
customized solutions through adhoc reports. These requests are delivered with
the perfect combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific
problems with right methodology of research is the key to help
enterprises reach right decision.”
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
